Serum lipid peroxidation and leptin levels in male and female type 2 diabetic patients in Gorgan (South East of Caspian Sea), Iran

Journal of Chinese Clinical Medicine

Volumn 5, Issue 1, 2010, Pages 26-35

  Marjani, Abdoljalal ^a   Veghari, Gholamreza ^a   Badeleh, Mohamad Taghi ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Leptin; Lipid peroxidation; Type 2 diabetes mellitus

Indexed keywords

INSULIN; LEPTIN; LIPID; MALONALDEHYDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HUMAN; HYPERLEPTINEMIA; INSULIN BLOOD LEVEL; IRAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77953384425     PISSN: 15629023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci, 2006,1084:1-29.
2. Azizi F, Guoya MM, Vazirian P, Dolatshati P, Habbibian S. Screening for type 2 diabetes in the Iranian national programme: a preliminary report. East Mediterr Health J, 2003,9:1122-1127.
3. Azizi F, Gouya MM, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. East Mediterr Health J, 2003,9:1114-1121.
4. Pari L, Latha M. Effect of Cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med J, 2002,43:617-621.
5. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes, 1991,40:405-412.
6. Wolff SP. The potential role of oxidative stress in diabetes and its complications: novel implications for theory and therapy. In: Crabbe MJC, ed. Diabetic Complications: Scientific and Clinical Aspects. London: Churchill Livingstone, 1987:167-221.
7. Varvarovská J, Racek J, Stetina R, et al. Aspects of oxidative stress in children with type 1 diabetes mellitus. Biomed Pharmacother, 2004,58:539-545.
8. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol, 2003,17:24-38.
9. Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun, 2005,338:668-676.
10. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol, 2005,205:1-16.
11. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem, 1997,43:1209-1214.
12. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis, 2005,15:316-328.
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue. Nature (London), 1994,372:425-432.
14. Wauters M, Considine RV & Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. European Journal of Endocrinology, 2000,143:293-311.
15. Tasaka Y, Yanagisawa K, Iwanoto Y. Human plasma leptin in obese subjects and diabetics. Endocr J, 1997,44:671-676.
16. Jianmeil L, Hasan A, Samuel DJ: Basal and stimulated plasma leptin in diabetic subjects. Obes Res, 1999,7:537-544.
17. Van Gaal LF, Wauters MA, Mertens IL, et al. Clinical endocrinology of human leptin. Int J Obes, 1999,23(suppl 1):29-36.
18. Lindgärde F, Söderberg S, Olsson T, et al. Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women. A dissociation contributing to low blood pressure? Metabolism, 2001,50:325-329.
19. Perez-Bravo F, Albala C, Sanotos JL, et al. Leptin levels distribution and ethnic background in two populations from Chile: Caucasian and Mapuche groups. Int J Obes Relat Metab Disord, 1998,22:943-948.
20. Wei M, Stern MP, Haffner SM. Serum leptin in Mexican American and non-Hispanic association with body mass index and cigarette smoking. Ann Epidmiol, 1997,7:81-86.
21. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by new colorimetric method. Clin Chim Acta, 1978,90:37-43.
22. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. Journal of Clinical Pathology, 1969,22:246.
23. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry, 1974,20:470-475.
24. Bucolo G, David H. Quantative determination of serum triglycerides by the use of enzymes. Clinical Chemistry, 1973,19:476-482.
25. Fruchart J C, Rev. Fr.Des laboratories, 1982,103:7.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972,18:499-502.
27. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol, 2003,17:24-38.
28. Sekeroglu MR, Sahin H, Dulger H, et al. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem, 2000,33:669-674.
29. Sundaram RK, Bhaskar A, Vijayalingam S, et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond), 1996,90:255-260.
30. Buyukkocak S, Ozturk H. S, Tamer M. N, Kacmaz M. Erythrocyte oxidant/antioxidant status of diabetic patients, J Endocrinol Invest, 2000,4:228-230.
31. Atli T, Keven K, Avci A, Kutlay S, Turkcaper N, Varli M, et al. Oxidative stress and antioxidant-status in elderly diabetes mellitus and glucose intolerance patients, Arch. Gerontol. Geriatr, 2004,39:269-275.
32. Marjani A, Moradi A, Saeedi M. Plasma lipid peroxidation zinc and erythrocyte cu-zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan City (South East of the Caspian Sea). Journal of Medical Sciences, 2007,7:585-590.
33. Maharjan BR, Jha JC, Adhikari D, Vishwanath P, Baxi J, Alurkar VM, Singh PP. A study of oxidative stress, antioxidant status and lipid profile in diabetic patient in the western region of Nepal. Kathmandu University Medical Journal, 2008,6:16-22.
34. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. Am. Soc-Biochem & Mol Biol, 1989,213:40-45.
35. Kannan K, Jain SK. Effect of high glucose on cellular proliferation and Lipid peroxidation in cultured verbo cells. Horm Met Res, 1994, 26:322-325.
36. Singh PP, Gupta S, Barjatiya MK, Mamtha GP, Adhikari D. Oxidant antioxidant dovetail hypothesis: Let us not sprint before we stand. In: Free Radicals and Antioxidants in Health and Disease. Udaipur, India. Eds & Pubs. Singh PP et al, Chaudhary Offset Print, 2007:1-31.
37. Midaoui AE, Champlain J. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. Journal of hypertension, 2005,23:581-588.
38. Houstis N, Evan D, Rosen, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 2006,440:944-948.
39. Wei M, Stern HM, Haffner SM. Serum leptin levels in Mexican American and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol, 1997,7:7-80.
40. Vettor R, De Pergola G, et al. Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest, 1997,27:1016-1024.
41. Tasaka Y, Yanagisawa K, Iwamoto Y. Human plasma leptin in obese subjects and diabetics. Endocr J, 1997,44:671-676.
42. Liuzzi A, Savia G, Tagliaferri M, et al. Serum leptin concentrations in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord, 1999,23:1066-1073.
43. Gomez-Ambrosi J, Salvador J, Paramo JA, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem, 2002,35:315-320.
44. Kieffer TJ, Heller RS, Leech CA, Holz G, Hebener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K-channels in pancreatic beta cells. Diabetes, 1997,46:1087-1093.
45. Berlin E, Rich N, Schneider N, et al. Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus. Diabetes Metab, 1998,24:229-234.
46. Johannsson G, Karlsson C, Lonn L, et al. Serum leptin concentration and insulin sensitivity in men with abdominal obesity. Obes Res, 1998,6:416-421.
47. Haluzik M, Matoulek M, Svacina S, Hilgertova J, Haas T. The influence of short term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res, 2001,27:251-260.
48. Hodge AM, Boyko EJ, de Courten M, et al. Leptin and other components of the metabolic syndrome in Mauritius * / a factor analysis. Int J Obes Relat Metab Disord, 2001,25:126-131.
49. Gulle K, Karaoz E. Leptinler. T Klin Tip Bilimleri, 2000,20:112-121.
50. Yamagishi S, Amano S, Inagaki Y, Okamoto T, Takeuchi M, Inoue H. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties, Microvasc Res, 2003,65:186-190.
51. Al-Daghri N, Al-Rubean K, BartlettWA, Al-Attas O, Jones AF, Kumar S: Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diab Med, 2003,20:832-837.
52. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, et al. Leptin and body fat in Type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab, 2003,88:1543-1553.
53. Abdelgadir M, Elbagir M, Eltom M, Berne C, Ahren B. Reduced leptin concentrations in subjects with Type 2 diabetes mellitus in Sudan. Metabolism, 2002,51:304-306.
54. Sayeed MA, Khan AKA, Mahtab HM, Ahsan KA, Banu A, Khanam PA, et al. Leptin is reduced in lean subjects with Type 2 diabetes in Bangladesh. Diab Care, 2000,26:547.
55. Haffner SM, Stern MP, Miethinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes, 1996,45:822-824.
56. Snehalatha C, Ramachandran A, Satyavani K, Sivasankuri S, Vijay V. Difference in body fat percentage does not explain the gender dimorphism in leptin in Asian Indians. J Assoc Physicians India, 1999,47:1164-1167.
57. Wauters M, Considine RV, Yudkin JS, Peiffer F, Deleeuw I, Van Gaal LF. Leptin levels in insulin resistance and insulin secretion. Hormone Metab Res, 2003,35:92-96.
58. Yamagishi S, Edelstein D, Du X. L, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase, J. Biol. Chem, 2001,276:25096-25100.
59. Gulen S and Dincer S. Effects of leptin on oxidative stress in healthy and Streptozotocin-induced diabetic rats. Mol Cell Biochem, 2007,302:59-65.
60. Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol, 1998,274:R1482-R1491
61. .Sivitz WI, Walsh S, Morgan D, Donohoue P, Haynes W, Leibel RL. Plasma leptin in diabetic and insulintreated diabetic and normal rats. Metabolism, 1998,47:584-591
62. Haluzik M, Nedvidkova J. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol Res, 2000,49:S37-S42.
63. Panarotto D, Ardilouze JL, Tessier D & Maheux P. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm. Metabolism, 2000,49:1055-1062.
64. Befowski J, Wo ó jcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia, Atherosclerosis, 2003,170:21-29.
65. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane, Metabolism, 2005,54:194-199.
66. Wei M, Stern HM, Haffner SM. Serum leptin levels in Mexican American and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol, 1997,7:79-80.
67. Vettor R, De Pergola G, et al. Gender differences in serum leptin in obese people: relationship with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest, 1997,27:1016-1024.
68. Tasaka Y, Yanagisawa K, Iwamoto Y. Human plasma leptin in obese subjects and diabetics. Endocr J, 1997,44:671-676.
69. Liuzzi A, Savia G, Tagliaferri M, et al. Serum leptin concentrations in moderate and severe obesity relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord, 1999,23:1066-1073.
70. Gomez-Ambrosi J, Salvador J, Paramo JA, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem, 2002,35:315-320.
71. Kieffer TJ, Heller RS, Leech CA, Holz G, Hebener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K-channels in pancreatic beta cells. Diabetes, 1997,46:1087-1093.
72. Berlin E, Rich N, Schneider N, et al. Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus. Diabetes Metab, 1998,24:229-234.
73. Johannsson G, Karlsson C, Lonn L, et al. Serum leptin concentration andinsulin sensitivity in men with abdominal obesity. Obes Res, 1998,6:416-421.
74. Haluzik M, Matoulek M, Svacina S, Hilgertova J, Haas T. The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res, 2001,27:251-260.
75. Hodge AM, Boyko EJ, de Courten M, et al. Leptin and other components of the metabolic syndrome in Mauritius * / a factor analysis. Int J Obes Relat Metab Disord, 2001,25:126-131.
76. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lammer C, Peiser C, Lang RE. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology, 1996,137:1501-1504.
77. Dagogo-Jack S, Liu J, Askari H, Tykodi G, Umamaheswaran I. Impaired leptin response to glucocorticoid as a chronic complication of diabetes. J Diabetes Complications, 2000,14:327-332.
78. Hattori A, Uemura K, Miura H, Ueda M, Tamaya N, Iwata F, Muraguchi M, Ohmoto Y, Iguchi A. Gender-related difference in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic and non-diabetic subjects. Endocr J, 2000,47:615-621.
79. Guler S, Cakir B, Demirbas B, Gursoy G, Serter R, Aral Y. Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. Diabetes Obesity Metab, 2000,2:313-316.
80. Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Fanelli A, Messeri G, Rotella CM. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with type 2 diabetes mellitus. Diabet Med, 2000,17:713-719.
81. Ozata M, Gungor D, Turan M, Ozisik G, Bingol N, Ozgurtas T, et al. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. J Clin Endocrinol Metab, 2001,86:3659-3664.
82. Abdelgadir M, Elbagir M, Eltom M, Berne C, Ahren B. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan. Metab Clin Exp, 2002,51:304-306.
83. Roden M, Ludwig C, Nowotny P, Schneider B, Clodi M, Vierhapper H, Roden A, Waldhausl W. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obesity Relat Metab Disord, 2000,24:976-981.
84. Kieffer TJ, Heller RS, Leech CA, Holz G, Hebener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K-channels in pancreatic beta cells. Diabetes, 1997,46:1087-1093.
85. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 1995,269:540-543.
86. Rossetti L, Massilon D, Barzilai N, et al. Short time effect of leptin on hepatic gluconeogenesis and invivo insulin action. J Biol Chem, 1997,272:27758-27763.
87. Clement K, Lahlou N, Ruiz J, et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Disord, 1997,21:556-561.